1. Chazova I.E., Oshchepkova E.V. Bor'ba s serdechno-sosudistymi zabolevaniyami: problemy i puti ikh resheniya na sovremennom etape. Vestnik Roszdravnadzora. 2015; 5: 7-10.
2. Wallentin L., Becker R.C., Budaj A., et al. PLATO Investigators. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2009; 361: 11: 1045-1057.
3. Mehta R.H., Sheng S., O'Brien S.M., et al. Reoperation for bleeding in patients undergoing coronary artery bypass surgery: incidence, risk factors, time trends, and outcomes. Circ. Cardiovasc. Qual. Outcomes. 2009; 2: 6: 583-590.
4. Shipulin V.M., Kozlov B.N., Krivoshchekov E.V, et al. Morfofunktsional'naya kharakteristika miokarda patsientov s postinfarktnym remodelirovaniem kak vozmozhnaya prichina neblagopriyatnykh rezul'tatov operativnogo lecheniya. Grudnaya i serdechno-sosudistaya khirurgiya. 2009; 5: 37-41.
5. Wiviott S.D., Braunwald E., McCabe C.H., et al. TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N. Engl. J. Med. 2007; 357: 2001-2015.